Aaron Wealth Advisors LLC raised its holdings in Colgate-Palmolive (NYSE:CL – Get Rating) by 7,524.4% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 543,928 shares of the company’s stock after purchasing an additional 536,794 shares during the quarter. Aaron Wealth Advisors LLC owned 0.06% of Colgate-Palmolive worth $7,173,000 at the end of the most recent reporting period.
Other large investors have also modified their holdings of the company. Horan Securities Inc. acquired a new position in shares of Colgate-Palmolive in the fourth quarter worth about $30,000. Carl Stuart Investment Advisor Inc. acquired a new position in shares of Colgate-Palmolive in the first quarter worth about $30,000. Riverview Trust Co acquired a new position in shares of Colgate-Palmolive in the first quarter worth about $38,000. US Asset Management LLC acquired a new position in shares of Colgate-Palmolive during the 1st quarter worth about $39,000. Finally, Industrial Alliance Investment Management Inc. acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth about $42,000. Institutional investors and hedge funds own 78.12% of the company’s stock.
Insider Buying and Selling
In other Colgate-Palmolive news, insider Jennifer Daniels sold 24,703 shares of the stock in a transaction that occurred on Thursday, August 4th. The shares were sold at an average price of $81.25, for a total transaction of $2,007,118.75. Following the sale, the insider now directly owns 48,163 shares in the company, valued at approximately $3,913,243.75. The transaction was disclosed in a document filed with the SEC, which is available through this link. In other news, CEO Noel R. Wallace sold 51,665 shares of the firm’s stock in a transaction on Thursday, August 4th. The shares were sold at an average price of $81.27, for a total value of $4,198,814.55. Following the sale, the chief executive officer now directly owns 221,790 shares in the company, valued at approximately $18,024,873.30. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Jennifer Daniels sold 24,703 shares of the firm’s stock in a transaction on Thursday, August 4th. The shares were sold at an average price of $81.25, for a total transaction of $2,007,118.75. Following the completion of the sale, the insider now owns 48,163 shares in the company, valued at $3,913,243.75. The disclosure for this sale can be found here. In the last quarter, insiders sold 126,368 shares of company stock valued at $10,172,933. Company insiders own 0.31% of the company’s stock.
Colgate-Palmolive Stock Performance
Colgate-Palmolive (NYSE:CL – Get Rating) last posted its quarterly earnings data on Friday, July 29th. The company reported $0.72 earnings per share for the quarter, topping analysts’ consensus estimates of $0.71 by $0.01. The firm had revenue of $4.48 billion during the quarter, compared to analysts’ expectations of $4.35 billion. Colgate-Palmolive had a net margin of 10.98% and a return on equity of 315.10%. The firm’s quarterly revenue was up 5.3% on a year-over-year basis. During the same quarter last year, the company posted $0.80 EPS. On average, analysts expect that Colgate-Palmolive will post 3.03 EPS for the current year.
Colgate-Palmolive Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Monday, August 15th. Investors of record on Thursday, July 21st were given a dividend of $0.47 per share. The ex-dividend date was Wednesday, July 20th. This represents a $1.88 dividend on an annualized basis and a dividend yield of 2.29%. Colgate-Palmolive’s payout ratio is currently 81.39%.
Analyst Upgrades and Downgrades
Several research analysts recently weighed in on the stock. UBS Group upped their price target on shares of Colgate-Palmolive from $88.00 to $90.00 and gave the stock a “buy” rating in a research report on Monday, August 1st. StockNews.com upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Tuesday, August 2nd. Wells Fargo & Company upgraded shares of Colgate-Palmolive to an “equal weight” rating in a research report on Tuesday, August 9th. Deutsche Bank Aktiengesellschaft reduced their price target on shares of Colgate-Palmolive from $88.00 to $87.00 in a research report on Tuesday, July 19th. Finally, TheStreet raised shares of Colgate-Palmolive from a “c+” rating to a “b” rating in a research note on Friday, April 29th. Twelve equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, Colgate-Palmolive has a consensus rating of “Hold” and a consensus target price of $84.57.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
- Get a free copy of the StockNews.com research report on Colgate-Palmolive (CL)
- Target’s Results Cap Upside Potential For Retail Stocks
- Are These 3 Video Game Stocks Now In Play?
- 2 Long-Term EV Plays Trading Under $20
- Why Apple is Primed to Take a Bite Out of Live Sports
- Exxon, Occidental Petroleum Lead Heavy Month Of Insider Buying
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.